Susanne Stowasser

Also affiliated with Boehringer Ingelheim (Egypt), Boehringer Ingelheim (China), Boehringer Ingelheim (United States)

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Nintedanib in children and adolescents with fibrosing interstitial lung diseases”.

Nintedanib in children and adolescents with fibrosing interstitial lung diseases

European Respiratory Journal(2022)10.1183/13993003.01512-2022

N/A

2.5DataRank · unranked

81 citations

Lisa R. Young, Emily M. DeBoer, David Warburton, Steve Cunningham, Nicolaus Schwerk +9 more

Trial of a Phosphodiesterase 4 Inhibitor for Idiopathic Pulmonary Fibrosis

New England Journal of Medicine(2022)10.1056/nejmc2209529

N/A

0.165DataRank · unranked

2 citations

Susanne Stowasser, Toby M. Maher, Luca Richeldi

Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosis

ERJ Open Research(2025)10.1183/23120541.00973-2025

N/A

0DataRank · unranked

0 citations

Francesco Bonella, Haruyuki Ishii, Joyce Lee, Elisabetta Renzoni, Sandra Hadl +5 more